U.S. Consumer Durables Stock News

With no single headline event driving attention today, investors are watching WaterBridge Infrastructure (WBI) following recent price swings and mixed return patterns over the past week, month, and past three months. See our latest analysis for WaterBridge Infrastructure. Over the year to date, WaterBridge Infrastructure’s share price has moved to $21.55, with a 7 day share price return of 6.89% and a 90 day share price return of an 11.75% decline, which suggests recent momentum has cooled...

Event context and recent share performance Collegium Pharmaceutical (COLL) has drawn attention after recent trading, with the share price at US$45.60 and returns showing a 2.8% decline over the past day and 5.3% decline over the past week. See our latest analysis for Collegium Pharmaceutical. While the recent 1 day and 7 day share price returns are negative, the 90 day share price return of 28.96% and 1 year total shareholder return of 36.73% suggest momentum has been building over a longer...

In early January 2026, Zymeworks reported positive Phase 3 HERIZON-GEA-01 results for its HER2-targeted therapy Ziihera in advanced gastroesophageal adenocarcinoma, alongside a series of leadership changes including new board and executive appointments and key retirements. A distinctive angle in this news is that the HERIZON-GEA-01 data could unlock up to US$440.0 million in potential approval-related milestones for Ziihera across the US, Europe, Japan, and China, adding financial...

As the U.S. market grapples with rising Treasury yields and uncertainty surrounding Federal Reserve decisions, investors are keenly observing potential opportunities amid recent index declines. In this environment, identifying undervalued stocks can be crucial for those looking to capitalize on discrepancies between market price and estimated value, as these stocks might offer growth potential despite broader economic challenges.

As the U.S. markets grapple with recent declines and rising Treasury yields, investors are keenly observing potential opportunities in various sectors. Penny stocks, while often seen as relics of past market trends, continue to offer intriguing possibilities for those willing to explore smaller or newer companies at accessible price points. By focusing on solid financials and growth potential, these stocks can present unique opportunities for investors looking to tap into under-the-radar...

As the U.S. market grapples with rising Treasury yields and a cautious Federal Reserve outlook, small-cap stocks are navigating a landscape marked by both challenges and opportunities. In this environment, identifying promising small caps requires a keen eye for companies with robust fundamentals that can weather economic fluctuations and capitalize on niche market demands.

The recent 11% drop in AIFU Inc.'s ( NASDAQ:AIFU ) stock could come as a blow to insiders who purchased CN¥12.3m worth...

We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits...

In recent days, Scotiabank and several other research firms shifted their views on American Homes 4 Rent, updating ratings and reassessing their outlook on the single‑family rental REIT. This cluster of analyst actions offers fresh information on how the market is reassessing American Homes 4 Rent’s risk‑reward profile and business outlook. Next, we’ll examine how this wave of analyst rating changes could influence American Homes 4 Rent’s investment narrative and future expectations. Rare...

Key Insights Given the large stake in the stock by institutions, Zhihu's stock price might be vulnerable to their...

Key Insights Aptera Motors' significant insider ownership suggests inherent interests in company's expansion A total of...

GoodRx Holdings (NASDAQ:GDRX) has had a rough three months with its share price down 31%. However, the company's...

The board of Carriage Services, Inc. ( NYSE:CSV ) has announced that it will pay a dividend on the 2nd of March, with...

Key Insights Significantly high institutional ownership implies Cytek Biosciences' stock price is sensitive to their...

With a median price-to-sales (or "P/S") ratio of close to 1.3x in the Commercial Services industry in the United...

The board of KeyCorp ( NYSE:KEY ) has announced that it will pay a dividend on the 13th of March, with investors...

We feel now is a pretty good time to analyse Sangamo Therapeutics, Inc.'s ( NASDAQ:SGMO ) business as it appears the...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Northwest Natural Holding Company's ( NYSE:NWN ) investors are due to receive a payment of $0.4925 per share on 13th of...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

ASP Isotopes Inc. recently completed its acquisition of Renergen Limited, appointing Renergen CEO Stefano Marani as President, Electronics and Space, and COO Nick Mitchell as Co-Chief Operating Officer, while multiple law firms began investigating potential fiduciary duty breaches and securities issues tied to allegations about the company’s nuclear fuel technology disclosures. This combination of integration of helium and natural gas operations with ASP Isotopes’ enrichment technology and...

NovaBay Pharmaceuticals (NBY) has reshaped its story with a private placement of pre funded warrants totaling about US$134 million, largely paid in digital assets, and a pivot toward a SKY token focused treasury model. See our latest analysis for NovaBay Pharmaceuticals. The financing news comes after a very sharp 30 day share price return of 178.68% and a very large 1 year total shareholder return, although the 3 and 5 year total shareholder returns are still deeply negative, so long term...

Annexon, Inc. recently submitted a Marketing Authorization Application to the European Medicines Agency for tanruprubart, a first-in-class antibody targeting complement-driven inflammation in Guillain-Barre syndrome, supported by randomized Phase 3 data and ongoing FORWARD study observations. This move underscores Annexon’s focus on severe neuroinflammatory diseases with limited treatment options, aiming to position tanruprubart as a potential new standard of care in GBS. We’ll now examine...

In early January 2026, Navient Corporation reshaped its leadership structure, appointing long-time executive Steve Hauber as Executive Vice President, Chief Financial Officer and Principal Accounting Officer, while Joe Fisher exited the CFO role and began a short transition period before leaving the company. By consolidating finance, legal, risk management, internal audit, and compliance under Hauber and expanding COO Troy Standish’s remit to technology and human resources, Navient is...